Sandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High – Should You Buy?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNYGet Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as $86.7999 and last traded at $86.35, with a volume of 4499 shares changing hands. The stock had previously closed at $81.62.

Sandoz Group Stock Up 4.9%

The firm’s 50-day moving average price is $75.93 and its 200-day moving average price is $67.17. The company has a quick ratio of 0.82, a current ratio of 1.29 and a debt-to-equity ratio of 0.62.

Sandoz Group Company Profile

(Get Free Report)

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.

Recommended Stories

Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.